Suppr超能文献

肉毒杆菌毒素治疗颈部肌张力障碍的疗效。评估方法的比较。

Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation.

作者信息

Odergren T, Tollbäck A, Borg J

机构信息

Department of Neurology, Karolinska Hospital, Stockholm, Sweden.

出版信息

Scand J Rehabil Med. 1994 Dec;26(4):191-5.

PMID:7878393
Abstract

Twenty patients with cervical dystonia were treated during one year with repeated intramuscular injections of botulinum toxin. The outcome was evaluated comparing subjective global rating with relative changes in degree of pain on the Visual analogue scale (VAS), degree of dysfunction due to dystonia, and quality of life according to the Nottingham health profile (NHP). Objective measurement of dystonic position and movement ability was performed using a goniometer, semiquantitatively noted as scores according to Fahn and Tsui. Before treatment, the degree of impaired life quality on the NHP did not correlate with the Tsui score of dystonic posture, but significantly with the Fahn score (p < 0.01) which also includes data on pain. Significant improvement after treatment was seen for all parameters (p < 0.05). Global subjective rating correlated significantly with improved posture according to the Tsui score (p < 0.05), but not with reduced pain or degree of dysfunction. The results suggest that the efficacy of botulinum toxin in cervical dystonia is best evaluated using a combination of the VAS for pain and the Tsui score for dystonic posture and movement ability.

摘要

在一年的时间里,对20例颈部肌张力障碍患者进行了反复肌肉注射肉毒杆菌毒素治疗。通过比较主观整体评分与视觉模拟量表(VAS)上疼痛程度的相对变化、肌张力障碍导致的功能障碍程度以及根据诺丁汉健康量表(NHP)得出的生活质量,对治疗结果进行了评估。使用角度计对肌张力障碍的姿势和运动能力进行客观测量,并根据Fahn和Tsui的方法半定量记录为分数。治疗前,NHP上生活质量受损程度与肌张力障碍姿势的Tsui评分无相关性,但与也包含疼痛数据的Fahn评分显著相关(p < 0.01)。治疗后所有参数均有显著改善(p < 0.05)。根据Tsui评分,整体主观评分与姿势改善显著相关(p < 0.05),但与疼痛减轻或功能障碍程度无关。结果表明,肉毒杆菌毒素治疗颈部肌张力障碍的疗效最好通过结合疼痛的VAS评分和肌张力障碍姿势及运动能力的Tsui评分来评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验